Cargando…

Biomarkers in osteoarthritis: current status and outlook — the FNIH Biomarkers Consortium PROGRESS OA study

Currently, no disease-modifying therapies are approved for osteoarthritis (OA) use. One obstacle to trial success in this field has been our existing endpoints’ limited validity and responsiveness. To overcome this impasse, the Foundation for the NIH OA Biomarkers Consortium is focused on investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hunter, David J., Collins, Jamie E., Deveza, Leticia, Hoffmann, Steven C., Kraus, Virginia B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509067/ https://www.ncbi.nlm.nih.gov/pubmed/36692532 http://dx.doi.org/10.1007/s00256-023-04284-w

Ejemplares similares

Semi-quantitative MRI biomarkers of knee osteoarthritis progression in the FNIH biomarkers consortium cohort − Methodologic aspects and definition of change
por: Roemer, Frank W., et al.
Publicado: (2016)

Association of quantitative measures of effusion-synovitis and hoffa-synovitis with radiographic and pain progression: Data from the FNIH OA biomarkers consortium
por: Smith, Stacy E., et al.
Publicado: (2021)

Development and evaluation of nomograms for predicting osteoarthritis progression based on MRI cartilage parameters: data from the FNIH OA biomarkers Consortium
por: Deng, Chunbo, et al.
Publicado: (2023)

Novel nomogram for predicting the progression of osteoarthritis based on 3D-MRI bone shape: data from the FNIH OA biomarkers consortium
por: Sun, Yingwei, et al.
Publicado: (2021)

Patterns of progression differ between Kellgren-Lawrence 2 and 3 knees fulfilling different definitions of a cartilage-meniscus phenotype in the Foundation for National Institutes of Health Osteoarthritis Biomarkers study (FNIH)
por: Roemer, Frank W., et al.
Publicado: (2022)

Investigation of a family affected by early-onset osteoarthritis – proposal of a clinical pathway and bioinformatics pipeline for the investigation of cases of familial OA
por: Deveza, Leticia A., et al.
Publicado: (2023)

Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2013)

The OA Trial Bank: Update of individual patient data meta-analysis of intra-articular glucocorticoids in persons with knee and hip osteoarthritis
por: Yu, Shirley P., et al.
Publicado: (2023)

Republished: Value of biomarkers in osteoarthritis: current status and perspectives
por: Lotz, M, et al.
Publicado: (2014)

Efficacy of bisphosphonates in specific knee osteoarthritis subpopulations: protocol for an OA Trial Bank systematic review and individual patient data meta-analysis
por: Deveza, Leticia A, et al.
Publicado: (2018)

A roadmap for serum biomarkers for hepatitis B virus: current status and future outlook
por: Kramvis, Anna, et al.
Publicado: (2022)

The Need for Predictive, Prognostic, Objective and Complementary Blood-Based Biomarkers in Osteoarthritis (OA)
por: Bay-Jensen, Anne-C., et al.
Publicado: (2016)

Use of acoustic emission to identify novel candidate biomarkers for knee osteoarthritis (OA)
por: Schlüter, Daniela K., et al.
Publicado: (2019)

Low-dose antibiotics: current status and outlook for the future
por: Nosanchuk, Joshua D., et al.
Publicado: (2014)

Assessment of Pain in Osteoarthritis of the Knee
por: Thirumaran, Aricia Jieqi, et al.
Publicado: (2023)

The FNIH Sarcopenia Project: Rationale, Study Description, Conference Recommendations, and Final Estimates
por: Studenski, Stephanie A., et al.
Publicado: (2014)

Biomarkers of prognosis and efficacy of treatment in OA
por: Henrotin, Yves
Publicado: (2015)

Biomarkers of Joint Damage in Osteoarthritis: Current Status and Future Directions
por: Kumavat, Rajkamal, et al.
Publicado: (2021)

Helium: Current Status And Future Outlook
por: Fowler, W B
Publicado: (1990)

DETERMINING THE PREVALENCE OF SARCOPENIA IN AN INPATIENT GERIATRIC POPULATION USING EWGSOP2 OR FNIH DEFINITIONS
por: Scholl, Matthew M, et al.
Publicado: (2019)

Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition
por: Dietzel, Roswitha, et al.
Publicado: (2022)

Mechanisms of Osteoarthritis (OA) Pain
por: O’Neill, Terence W., et al.
Publicado: (2018)

MR-Imaging in Osteoarthritis: Current Standard of Practice and Future Outlook
por: Ehmig, Jonathan, et al.
Publicado: (2023)

Adaptive designs: current status, future outlook
por: Grieve, Andy
Publicado: (2011)

Aurora Kinase Inhibitors: Current Status and Outlook
por: Bavetsias, Vassilios, et al.
Publicado: (2015)

Current Status and Future Outlook for Nonwovens in Japan
por: Yaida, Osamu
Publicado: (2016)

Current status and outlook of advances in exosome isolation
por: Liu, Wen-zhao, et al.
Publicado: (2022)

Establishing a consortium for Open Access (OA) publishing in particle physics
por: Dallman, David Peter, et al.
Publicado: (2006)

BioDynaMo: Current Status and Future Outlook
por: Breitwieser, Lukas
Publicado: (2021)

Determination of Drugs in Clinical Trials: Current Status and Outlook
por: Tavana, Babak, et al.
Publicado: (2022)

Diffuse correlation spectroscopy: current status and future outlook
por: Carp, Stefan A., et al.
Publicado: (2023)

Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis
por: Ritter, Susan Y, et al.
Publicado: (2014)

First Qualification Study of Serum Biomarkers as Indicators of Total Body Burden of Osteoarthritis
por: Kraus, Virginia B., et al.
Publicado: (2010)

CLIC Status and Outlook
por: Stapnes, Stapnes
Publicado: (2012)

HCC biomarkers – state of the old and outlook to future promising biomarkers and their potential in everyday clinical practice
por: Schlosser, Sophie, et al.
Publicado: (2022)

A “best-in-class” systemic biomarker predictor of clinically relevant knee osteoarthritis structural and pain progression
por: Zhou, Kaile, et al.
Publicado: (2023)

Biomarkers in osteoarthritis
por: Williams, Frances MK, et al.
Publicado: (2008)

Biomarkers in Osteoarthritis
por: Sandell, Linda J.
Publicado: (2012)

Clinical Utility of Microarrays: Current Status, Existing Challenges and Future Outlook
por: Li, Xinmin, et al.
Publicado: (2008)

Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future
por: Prins, Niels D, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vce6oglfll6gdn3vnfeie8os8c